Literature DB >> 30182253

Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.

Chuangen Guo1, Xiaoling Zhuge2, Zhongqiu Wang3, Qidong Wang1, Ke Sun4, Zhan Feng5, Xiao Chen6.   

Abstract

PURPOSE: Grades of pancreatic neuroendocrine neoplasms (PNENs) are associated with the choice of treatment strategies. Texture analysis has been used in tumor diagnosis and staging evaluation. In this study, we aim to evaluate the potential ability of texture parameters in differentiation of PNENs grades.
MATERIALS AND METHODS: 37 patients with histologically proven PNENs and underwent pretreatment dynamic contrast-enhanced computed tomography examinations were retrospectively analyzed. Imaging features and texture features at contrast-enhanced images were evaluated. Receiver operating characteristic curves were used to determine the cut-off values and the sensitivity and specificity of prediction.
RESULTS: There were significant differences in tumor margin, pancreatic duct dilatation, lymph nodes invasion, size, portal enhancement ratio (PER), arterial enhancement ratio (AER), mean grey-level intensity, kurtosis, entropy, and uniformity among G1, G2, and pancreatic neuroendocrine carcinoma (PNEC) G3 (p < 0.01). Similar results were found between pancreatic neuroendocrine tumors (PNETs) G1/G2 and PNEC G3. AER and PER showed the best sensitivity (0.86-0.94) and specificity (0.92-1.0) for differentiating PNEC G3 from PNETs G1/G2. Mean grey-level intensity, entropy, and uniformity also showed acceptable sensitivity (0.73-0.91) and specificity (0.85-1.0). Mean grey-level intensity was also showed acceptable sensitivity (91% to 100%) and specificity (82% to 91%) in differentiating PNET G1 from PNET G2.
CONCLUSIONS: Our data indicated that texture parameters have potential in grading PNENs, in particular in differentiating PNEC G3 from PNETs G1/G2.

Entities:  

Keywords:  Computed tomography; Grade; Pancreatic neuroendocrine carcinoma; Pancreatic neuroendocrine neoplasms; Texture analysis

Mesh:

Substances:

Year:  2019        PMID: 30182253     DOI: 10.1007/s00261-018-1763-1

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  13 in total

1.  Retrospective Analysis of the Value of Enhanced CT Radiomics Analysis in the Differential Diagnosis Between Pancreatic Cancer and Chronic Pancreatitis.

Authors:  Xi Ma; Yu-Rui Wang; Li-Yong Zhuo; Xiao-Ping Yin; Jia-Liang Ren; Cai-Ying Li; Li-Hong Xing; Tong-Tong Zheng
Journal:  Int J Gen Med       Date:  2022-01-06

Review 2.  New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms.

Authors:  Mohammed Saleh; Priya R Bhosale; Motoyo Yano; Malak Itani; Ahmed K Elsayes; Daniel Halperin; Emily K Bergsland; Ajaykumar C Morani
Journal:  Abdom Radiol (NY)       Date:  2020-10-23

Review 3.  Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Andrew Canakis; Linda S Lee
Journal:  World J Gastrointest Endosc       Date:  2022-05-16

4.  Differentiation Between G1 and G2/G3 Phyllodes Tumors of Breast Using Mammography and Mammographic Texture Analysis.

Authors:  Wen Jing Cui; Cheng Wang; Ling Jia; Shuai Ren; Shao Feng Duan; Can Cui; Xiao Chen; Zhong Qiu Wang
Journal:  Front Oncol       Date:  2019-05-29       Impact factor: 6.244

5.  Differentiation of chronic mass-forming pancreatitis from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.

Authors:  Shuai Ren; Xiao Chen; Wenjing Cui; Rong Chen; Kai Guo; Huifeng Zhang; Shuai Chen; Zhongqiu Wang
Journal:  Cancer Manag Res       Date:  2019-08-20       Impact factor: 3.989

6.  Application of Radiomics Analysis Based on CT Combined With Machine Learning in Diagnostic of Pancreatic Neuroendocrine Tumors Patient's Pathological Grades.

Authors:  Tao Zhang; YueHua Zhang; Xinglong Liu; Hanyue Xu; Chaoyue Chen; Xuan Zhou; Yichun Liu; Xuelei Ma
Journal:  Front Oncol       Date:  2021-02-11       Impact factor: 6.244

7.  A [68Ga]Ga-DOTANOC PET/CT Radiomic Model for Non-Invasive Prediction of Tumour Grade in Pancreatic Neuroendocrine Tumours.

Authors:  Alessandro Bevilacqua; Diletta Calabrò; Silvia Malavasi; Claudio Ricci; Riccardo Casadei; Davide Campana; Serena Baiocco; Stefano Fanti; Valentina Ambrosini
Journal:  Diagnostics (Basel)       Date:  2021-05-12

Review 8.  Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions.

Authors:  Anna Pellat; Anne Ségolène Cottereau; Lola-Jade Palmieri; Philippe Soyer; Ugo Marchese; Catherine Brezault; Romain Coriat
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

9.  Quantitative Computed Tomography Image Analysis to Predict Pancreatic Neuroendocrine Tumor Grade.

Authors:  Alessandra Pulvirenti; Rikiya Yamashita; Jayasree Chakraborty; Natally Horvat; Kenneth Seier; Caitlin A McIntyre; Sharon A Lawrence; Abhishek Midya; Maura A Koszalka; Mithat Gonen; David S Klimstra; Diane L Reidy; Peter J Allen; Richard K G Do; Amber L Simpson
Journal:  JCO Clin Cancer Inform       Date:  2021-06

10.  Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.

Authors:  Christian Philipp Reinert; Karolin Baumgartner; Tobias Hepp; Michael Bitzer; Marius Horger
Journal:  Abdom Radiol (NY)       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.